Hypercalcemia caused by vitamin D3 analogs in psoriasis treatment
Authors:
- 18 December 2007
- journal article
- Published by Wiley in International Journal of Dermatology
- Vol. 46 (12) , 1315-1317
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Severe hypercalcemia and hypernatremia associated with calcipotriol for treatment of psoriasisJournal of Bone and Mineral Metabolism, 2004
- Topical preparations for the treatment of psoriasis: a systematic reviewBritish Journal of Dermatology, 2002
- Hypercalcaemia and Hypercalciuria after Topical Treatment of Psoriasis with Excessive Amounts of CalcipotriolActa Dermato-Venereologica, 1999
- The effects of topical calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasisJournal of the American Academy of Dermatology, 1997
- High dose topical calcipotriol consistently reduces serum parathyroid hormone levelsClinical Endocrinology, 1994
- Hypercalcaemia during treatment of psoriasis with calcipotriplBritish Journal of Dermatology, 1994
- Hypercalcaemic crisis after excessive topical use of a vitamin D derivativeJournal of Internal Medicine, 1994
- Urine calcium excretion during treatment of psoriasis with topical calcipotriolBritish Journal of Dermatology, 1993
- Hypercalcaemia associated with calcipotriol (Dovonex) treatment.BMJ, 1993
- Calcipotriol and hypercalcaemiaThe Lancet, 1991